MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, FDMT made $90,000 in revenue. -$56,876,000 in net income. Net profit margin of -63195.56%.

Income Overview

Revenue
$90,000
Net Income
-$56,876,000
Net Profit Margin
-63195.56%
EPS
-$1.01
Unit: Dollar

Unit: Dollar
Income Statement
2025-09-30
2025-06-30
2025-03-31
2024-12-31
Collaboration and license revenue
90,000 15,000 14,000 11,333.333
Research and development
49,438,000 47,951,000 40,699,000 34,271,666.667
General and administrative
11,837,000 11,520,000 12,936,000 11,309,333.333
Total operating expenses
61,275,000 59,471,000 53,635,000 45,581,000
Loss from operations
-61,185,000 -59,456,000 -53,621,000 -45,569,666.667
Interest income
4,330,000 4,859,000 5,582,000 6,586,666.667
Other income (expense), net
-21,000 -61,000 67,000 -25,333.333
Total other income, net
4,309,000 4,798,000 5,649,000 6,561,333.333
Net loss
-56,876,000 -54,658,000 -47,972,000 -39,008,333.333
Earnings per share, basic
-1.01 -0.98 -0.86 -0.73
Earnings per share, diluted
-1.01 -0.98 -0.86 -0.73
Weighted average number of shares outstanding, basic
56,126,330 55,927,091 55,744,047 -536,911.667
Weighted average number of shares outstanding, diluted
56,126,330 55,927,091 55,744,047 -536,911.667
Unit: Dollar

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Interest income$4,330,000 Net loss-$56,876,000 Total other income,net$4,309,000 Other income(expense), net-$21,000 Loss from operations-$61,185,000 Collaboration and licenserevenue$90,000 Total operatingexpenses$61,275,000 General andadministrative$11,837,000 Research and development$49,438,000

4D Molecular Therapeutics, Inc. (FDMT)

4D Molecular Therapeutics, Inc. (FDMT)